// App-Quantinova.ai

: Should the D1152H variant be included in cystic fibrosis newborn screening programmes?

Researchers

Presenter

  • Carwyn Dafydd

Principal Investigators

  • Kevin W. Southern

  • Stuart Moat

  • Iolo J.M. Doull

Medical Centers

  • Department of Paediatric Respiratory Medicine and Paediatric Cystic Fibrosis Centre, Children's Hospital for Wales, Cardiff, United Kingdom

  • Institute of Child Health Department of Womens and Childrens Health,University of Liverpool, Liverpool, United Kingdom

  • Department of Medical Biochemistry, Immunology & Toxicology, University Hospital of Wales, Cardiff, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • Cystic Fibrosis

Biomarkers

  • Nibrin

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved